1M8X - Header Asymmetric Unit

HEADER RNA BINDING PROTEIN/RNA 26-JUL-02 1M8X

TITLE CRYSTAL STRUCTURE OF THE PUMILIO-HOMOLOGY DOMAIN FROM HUMAN TITLE 2 PUMILIO1 IN COMPLEX WITH NRE1-14 RNA

COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5'-R(P*UP*UP*GP*UP*AP*UP*AP*U)-3'; COMPND 3 CHAIN: C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: 5'-R(P*UP*GP*UP*AP*UP*AP*U)-3'; COMPND 7 CHAIN: D; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: PUMILIO 1; COMPND 11 CHAIN: A, B; COMPND 12 FRAGMENT: PUMILIO-HOMOLOGY DOMAIN, RESIDUES 828-1176; COMPND 13 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN SOURCE 4 DROSOPHILA MELANOGASTER; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN SOURCE 8 DROSOPHILA MELANOGASTER; SOURCE 9 MOL_ID: 3; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 14 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 15 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 16 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 17 EXPRESSION_SYSTEM_PLASMID: PTYB3

KEYWDS PUMILIO-HOMOLOGY DOMAIN, PUF DOMAIN, NANOS RESPONSE ELEMENT, KEYWDS 2 RNA BINDING PROTEIN/RNA COMPLEX

EXPDTA X-RAY DIFFRACTION

AUTHOR X.WANG,J.MCLACHLAN,P.D.ZAMORE,T.M.T.HALL

REVDAT 2 24-FEB-09 1M8X 1 VERSN REVDAT 1 25-SEP-02 1M8X 0

JRNL AUTH X.WANG,J.MCLACHLAN,P.D.ZAMORE,T.M.T.HALL JRNL TITL MODULAR RECOGNITION OF RNA BY A HUMAN JRNL TITL 2 PUMILIO-HOMOLOGY DOMAIN JRNL REF CELL(CAMBRIDGE,MASS.) V. 110 501 2002 JRNL REFN ISSN 0092-8674 JRNL PMID 12202039 JRNL DOI 10.1016/S0092-8674(02)00873-5

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH X.WANG,P.D.ZAMORE,T.M.T.HALL REMARK 1 TITL CRYSTAL STRUCTURE OF A PUMILIO HOMOLOGY DOMAIN REMARK 1 REF MOL.CELL V. 7 855 2001 REMARK 1 REFN ISSN 1097-2765 REMARK 1 DOI 10.1016/S1097-2765(01)00229-5

REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.29 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.7 REMARK 3 NUMBER OF REFLECTIONS : 37951 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.293 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2296 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5371 REMARK 3 BIN R VALUE (WORKING SET) : 0.3200 REMARK 3 BIN FREE R VALUE : 0.3600 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 352 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.019 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5550 REMARK 3 NUCLEIC ACID ATOMS : 314 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 493 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -7.39000 REMARK 3 B22 (A**2) : 5.25000 REMARK 3 B33 (A**2) : 2.15000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.61000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.36 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.83 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.130 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.200 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.330 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.670 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 57.16 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : BME.PARAM REMARK 3 PARAMETER FILE 4 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED

REMARK 4 REMARK 4 1M8X COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-AUG-02. REMARK 100 THE RCSB ID CODE IS RCSB016743.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAR-01 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : YALE MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39467 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 500.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.34300 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1IB3 REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, LITHIUM SULFATE, SODIUM REMARK 280 CITRATE, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 131.36500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 18.86500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 131.36500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 18.86500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: TWO BIOLOGICAL UNITS ARE CONTAINED IN THE ASYMMETRIC REMARK 300 UNIT.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1169 REMARK 465 LYS A 1170 REMARK 465 ASN A 1171 REMARK 465 GLY A 1172 REMARK 465 VAL A 1173 REMARK 465 ASP A 1174 REMARK 465 LEU A 1175 REMARK 465 GLY A 1176 REMARK 465 MET B 1169 REMARK 465 LYS B 1170 REMARK 465 ASN B 1171 REMARK 465 GLY B 1172 REMARK 465 VAL B 1173 REMARK 465 ASP B 1174 REMARK 465 LEU B 1175 REMARK 465 GLY B 1176

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 838 16.58 -68.30 REMARK 500 TYR A 841 75.55 -114.49 REMARK 500 LEU A 868 36.44 -87.35 REMARK 500 LYS A 869 -40.26 -137.34 REMARK 500 SER B 830 159.40 -36.49 REMARK 500 ASN B 839 1.29 50.38 REMARK 500 ASN B 843 66.89 -113.53 REMARK 500 PRO B 946 163.61 -49.64 REMARK 500 HIS B1032 14.42 -148.23 REMARK 500 HIS B1147 22.85 -75.03 REMARK 500 ALA B1149 -88.82 -40.45 REMARK 500 THR B1150 0.26 -62.68 REMARK 500 GLU B1165 5.84 -57.03 REMARK 500 TYR B1167 49.23 -159.53 REMARK 500 REMARK 500 REMARK: NULL

REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 139 DISTANCE = 5.46 ANGSTROMS REMARK 525 HOH B 388 DISTANCE = 5.54 ANGSTROMS REMARK 525 HOH B 402 DISTANCE = 5.36 ANGSTROMS REMARK 525 HOH A 414 DISTANCE = 5.50 ANGSTROMS REMARK 525 HOH A 463 DISTANCE = 5.40 ANGSTROMS

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IB3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A PUMILIO-HOMOLOGY DOMAIN REMARK 900 RELATED ID: 1IB2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A PUMILIO-HOMOLOGY DOMAIN REMARK 900 RELATED ID: 1M8W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PUMILIO-HOMOLOGY DOMAIN FROM HUMAN REMARK 900 PUMILIO1 IN COMPLEX WITH NRE1-14 RNA REMARK 900 RELATED ID: 1M8Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PUMILIO-HOMOLOGY DOMAIN FROM HUMAN REMARK 900 PUMILIO1 IN COMPLEX WITH NRE2-10 RNA

DBREF 1M8X A 828 1176 UNP Q14671 PUM1_HUMAN 828 1176 DBREF 1M8X B 828 1176 UNP Q14671 PUM1_HUMAN 828 1176 DBREF 1M8X C 12 19 PDB 1M8X 1M8X 12 19 DBREF 1M8X D 13 19 PDB 1M8X 1M8X 13 19

SEQRES 1 C 8 U U G U A U A U SEQRES 1 D 7 U G U A U A U SEQRES 1 A 349 GLY ARG SER ARG LEU LEU GLU ASP PHE ARG ASN ASN ARG SEQRES 2 A 349 TYR PRO ASN LEU GLN LEU ARG GLU ILE ALA GLY HIS ILE SEQRES 3 A 349 MET GLU PHE SER GLN ASP GLN HIS GLY SER ARG PHE ILE SEQRES 4 A 349 GLN LEU LYS LEU GLU ARG ALA THR PRO ALA GLU ARG GLN SEQRES 5 A 349 LEU VAL PHE ASN GLU ILE LEU GLN ALA ALA TYR GLN LEU SEQRES 6 A 349 MET VAL ASP VAL PHE GLY ASN TYR VAL ILE GLN LYS PHE SEQRES 7 A 349 PHE GLU PHE GLY SER LEU GLU GLN LYS LEU ALA LEU ALA SEQRES 8 A 349 GLU ARG ILE ARG GLY HIS VAL LEU SER LEU ALA LEU GLN SEQRES 9 A 349 MET TYR GLY CYS ARG VAL ILE GLN LYS ALA LEU GLU PHE SEQRES 10 A 349 ILE PRO SER ASP GLN GLN ASN GLU MET VAL ARG GLU LEU SEQRES 11 A 349 ASP GLY HIS VAL LEU LYS CYS VAL LYS ASP GLN ASN GLY SEQRES 12 A 349 ASN HIS VAL VAL GLN LYS CYS ILE GLU CYS VAL GLN PRO SEQRES 13 A 349 GLN SER LEU GLN PHE ILE ILE ASP ALA PHE LYS GLY GLN SEQRES 14 A 349 VAL PHE ALA LEU SER THR HIS PRO TYR GLY CYS ARG VAL SEQRES 15 A 349 ILE GLN ARG ILE LEU GLU HIS CYS LEU PRO ASP GLN THR SEQRES 16 A 349 LEU PRO ILE LEU GLU GLU LEU HIS GLN HIS THR GLU GLN SEQRES 17 A 349 LEU VAL GLN ASP GLN TYR GLY ASN TYR VAL ILE GLN HIS SEQRES 18 A 349 VAL LEU GLU HIS GLY ARG PRO GLU ASP LYS SER LYS ILE SEQRES 19 A 349 VAL ALA GLU ILE ARG GLY ASN VAL LEU VAL LEU SER GLN SEQRES 20 A 349 HIS LYS PHE ALA SER ASN VAL VAL GLU LYS CYS VAL THR SEQRES 21 A 349 HIS ALA SER ARG THR GLU ARG ALA VAL LEU ILE ASP GLU SEQRES 22 A 349 VAL CYS THR MET ASN ASP GLY PRO HIS SER ALA LEU TYR SEQRES 23 A 349 THR MET MET LYS ASP GLN TYR ALA ASN TYR VAL VAL GLN SEQRES 24 A 349 LYS MET ILE ASP VAL ALA GLU PRO GLY GLN ARG LYS ILE SEQRES 25 A 349 VAL MET HIS LYS ILE ARG PRO HIS ILE ALA THR LEU ARG SEQRES 26 A 349 LYS TYR THR TYR GLY LYS HIS ILE LEU ALA LYS LEU GLU SEQRES 27 A 349 LYS TYR TYR MET LYS ASN GLY VAL ASP LEU GLY SEQRES 1 B 349 GLY ARG SER ARG LEU LEU GLU ASP PHE ARG ASN ASN ARG SEQRES 2 B 349 TYR PRO ASN LEU GLN LEU ARG GLU ILE ALA GLY HIS ILE SEQRES 3 B 349 MET GLU PHE SER GLN ASP GLN HIS GLY SER ARG PHE ILE SEQRES 4 B 349 GLN LEU LYS LEU GLU ARG ALA THR PRO ALA GLU ARG GLN SEQRES 5 B 349 LEU VAL PHE ASN GLU ILE LEU GLN ALA ALA TYR GLN LEU SEQRES 6 B 349 MET VAL ASP VAL PHE GLY ASN TYR VAL ILE GLN LYS PHE SEQRES 7 B 349 PHE GLU PHE GLY SER LEU GLU GLN LYS LEU ALA LEU ALA SEQRES 8 B 349 GLU ARG ILE ARG GLY HIS VAL LEU SER LEU ALA LEU GLN SEQRES 9 B 349 MET TYR GLY CYS ARG VAL ILE GLN LYS ALA LEU GLU PHE SEQRES 10 B 349 ILE PRO SER ASP GLN GLN ASN GLU MET VAL ARG GLU LEU SEQRES 11 B 349 ASP GLY HIS VAL LEU LYS CYS VAL LYS ASP GLN ASN GLY SEQRES 12 B 349 ASN HIS VAL VAL GLN LYS CYS ILE GLU CYS VAL GLN PRO SEQRES 13 B 349 GLN SER LEU GLN PHE ILE ILE ASP ALA PHE LYS GLY GLN SEQRES 14 B 349 VAL PHE ALA LEU SER THR HIS PRO TYR GLY CYS ARG VAL SEQRES 15 B 349 ILE GLN ARG ILE LEU GLU HIS CYS LEU PRO ASP GLN THR SEQRES 16 B 349 LEU PRO ILE LEU GLU GLU LEU HIS GLN HIS THR GLU GLN SEQRES 17 B 349 LEU VAL GLN ASP GLN TYR GLY ASN TYR VAL ILE GLN HIS SEQRES 18 B 349 VAL LEU GLU HIS GLY ARG PRO GLU ASP LYS SER LYS ILE SEQRES 19 B 349 VAL ALA GLU ILE ARG GLY ASN VAL LEU VAL LEU SER GLN SEQRES 20 B 349 HIS LYS PHE ALA SER ASN VAL VAL GLU LYS CYS VAL THR SEQRES 21 B 349 HIS ALA SER ARG THR GLU ARG ALA VAL LEU ILE ASP GLU SEQRES 22 B 349 VAL CYS THR MET ASN ASP GLY PRO HIS SER ALA LEU TYR SEQRES 23 B 349 THR MET MET LYS ASP GLN TYR ALA ASN TYR VAL VAL GLN SEQRES 24 B 349 LYS MET ILE ASP VAL ALA GLU PRO GLY GLN ARG LYS ILE SEQRES 25 B 349 VAL MET HIS LYS ILE ARG PRO HIS ILE ALA THR LEU ARG SEQRES 26 B 349 LYS TYR THR TYR GLY LYS HIS ILE LEU ALA LYS LEU GLU SEQRES 27 B 349 LYS TYR TYR MET LYS ASN GLY VAL ASP LEU GLY

FORMUL 5 HOH *493(H2 O)

HELIX 1 1 SER A 830 ASN A 838 1 9 HELIX 2 2 LEU A 846 ALA A 850 5 5 HELIX 3 3 HIS A 852 GLN A 858 1 7 HELIX 4 4 ASP A 859 GLU A 871 1 13 HELIX 5 5 THR A 874 LEU A 886 1 13 HELIX 6 6 ALA A 888 VAL A 894 1 7 HELIX 7 7 GLY A 898 GLY A 909 1 12 HELIX 8 8 SER A 910 ARG A 922 1 13 HELIX 9 9 HIS A 924 LEU A 930 1 7 HELIX 10 10 TYR A 933 ILE A 945 1 13 HELIX 11 11 PRO A 946 GLU A 956 1 11 HELIX 12 12 HIS A 960 LYS A 966 1 7 HELIX 13 13 ASN A 969 VAL A 981 1 13 HELIX 14 14 GLN A 982 SER A 985 5 4 HELIX 15 15 LEU A 986 LYS A 994 1 9 HELIX 16 16 GLN A 996 THR A 1002 1 7 HELIX 17 17 TYR A 1005 CYS A 1017 1 13 HELIX 18 18 LEU A 1018 HIS A 1032 1 15 HELIX 19 19 HIS A 1032 GLN A 1038 1 7 HELIX 20 20 TYR A 1041 GLY A 1053 1 13 HELIX 21 21 ARG A 1054 ARG A 1066 1 13 HELIX 22 22 ASN A 1068 GLN A 1074 1 7 HELIX 23 23 PHE A 1077 ALA A 1089 1 13 HELIX 24 24 SER A 1090 MET A 1104 1 15 HELIX 25 25 ALA A 1111 ASP A 1118 1 8 HELIX 26 26 TYR A 1120 ALA A 1132 1 13 HELIX 27 27 GLU A 1133 ARG A 1145 1 13 HELIX 28 28 HIS A 1147 ARG A 1152 1 6 HELIX 29 29 TYR A 1156 LYS A 1166 1 11 HELIX 30 30 SER B 830 ASN B 838 1 9 HELIX 31 31 GLN B 845 ALA B 850 5 6 HELIX 32 32 HIS B 852 GLN B 858 1 7 HELIX 33 33 ASP B 859 GLU B 871 1 13 HELIX 34 34 THR B 874 LEU B 886 1 13 HELIX 35 35 ALA B 888 VAL B 894 1 7 HELIX 36 36 PHE B 897 GLY B 909 1 13 HELIX 37 37 SER B 910 ARG B 922 1 13 HELIX 38 38 HIS B 924 LEU B 930 1 7 HELIX 39 39 TYR B 933 ILE B 945 1 13 HELIX 40 40 PRO B 946 ASP B 958 1 13 HELIX 41 41 HIS B 960 LYS B 966 1 7 HELIX 42 42 ASN B 969 VAL B 981 1 13 HELIX 43 43 GLN B 982 SER B 985 5 4 HELIX 44 44 LEU B 986 LYS B 994 1 9 HELIX 45 45 GLN B 996 THR B 1002 1 7 HELIX 46 46 TYR B 1005 CYS B 1017 1 13 HELIX 47 47 LEU B 1018 HIS B 1030 1 13 HELIX 48 48 HIS B 1032 VAL B 1037 1 6 HELIX 49 49 TYR B 1041 GLY B 1053 1 13 HELIX 50 50 ARG B 1054 ARG B 1066 1 13 HELIX 51 51 ASN B 1068 GLN B 1074 1 7 HELIX 52 52 PHE B 1077 ALA B 1089 1 13 HELIX 53 53 SER B 1090 MET B 1104 1 15 HELIX 54 54 ALA B 1111 LYS B 1117 1 7 HELIX 55 55 TYR B 1120 ALA B 1132 1 13 HELIX 56 56 GLU B 1133 ARG B 1145 1 13 HELIX 57 57 PRO B 1146 TYR B 1154 5 9 HELIX 58 58 GLY B 1157 GLU B 1165 1 9

SHEET 1 A 2 ASN A1105 ASP A1106 0 SHEET 2 A 2 HIS A1109 SER A1110 -1 O HIS A1109 N ASP A1106 SHEET 1 B 2 ASN B1105 ASP B1106 0 SHEET 2 B 2 HIS B1109 SER B1110 -1 O HIS B1109 N ASP B1106

CRYST1 262.730 37.730 82.520 90.00 102.95 90.00 C 1 2 1 8

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.003806 0.000000 0.000875 0.00000

SCALE2 0.000000 0.026504 0.000000 0.00000

SCALE3 0.000000 0.000000 0.012435 0.00000